- call +1-201-465-4211
- email sales@mrinsights.biz
Neurosyphilis is an infection of the brain or spinal cord caused by the spirochete Treponema pallidum. It usually occurs in people who have had chronic, untreated syphilis, usually about 10 to 20 years after first infection and develops in about 25%–40% of those who are not treated. The United States' Centers for Disease Control and Prevention (CDC) advises that neurosyphilis can occur at any stage of a syphilis infection.
Scope of the Report:
This report studies the Neurosyphilis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neurosyphilis market by product type and applications/end industries.
Neurosyphilis has four different forms: asymptomatic, meningovascular, tabes dorsalis, and general paresis. In rare instances, active neurosyphilis can mimic Alzheimer's disease. In addition to evaluation of any symptoms and signs, various blood tests can be done. Additional tests to look for problems with the nervous system may include Cerebral angiogram, Head CT scan, Lumbar puncture and MRI scan of the brain, brainstem, or spinal cord.
The global Neurosyphilis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neurosyphilis.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott
Bayer
Eli Lilly and Company
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Asymptomatic Neurosyphilis
Meningeal Neurosyphilis
Meningovascular Neurosyphilis
General Paresis
Tabes Dorsalis
Market Segment by Applications, can be divided into
Hospital And Clinics
Medical Research Centers
Academic Institutes
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Neurosyphilis Market Overview
1.1 Product Overview and Scope of Neurosyphilis
1.2 Classification of Neurosyphilis by Types
1.2.1 Global Neurosyphilis Revenue Comparison by Types (2017-2023)
1.2.2 Global Neurosyphilis Revenue Market Share by Types in 2017
1.2.3 Asymptomatic Neurosyphilis
1.2.4 Meningeal Neurosyphilis
1.2.5 Meningovascular Neurosyphilis
1.2.6 General Paresis
1.2.7 Tabes Dorsalis
1.3 Global Neurosyphilis Market by Application
1.3.1 Global Neurosyphilis Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital And Clinics
1.3.3 Medical Research Centers
1.3.4 Academic Institutes
1.4 Global Neurosyphilis Market by Regions
1.4.1 Global Neurosyphilis Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Neurosyphilis Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Neurosyphilis Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neurosyphilis Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Neurosyphilis Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neurosyphilis Status and Prospect (2013-2023)
1.5 Global Market Size of Neurosyphilis (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Neurosyphilis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Neurosyphilis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly and Company
2.3.1 Business Overview
2.3.2 Neurosyphilis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly and Company Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Neurosyphilis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Neurosyphilis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Neurosyphilis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Neurosyphilis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
3 Global Neurosyphilis Market Competition, by Players
3.1 Global Neurosyphilis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Neurosyphilis Players Market Share
3.2.2 Top 10 Neurosyphilis Players Market Share
3.3 Market Competition Trend
4 Global Neurosyphilis Market Size by Regions
4.1 Global Neurosyphilis Revenue and Market Share by Regions
4.2 North America Neurosyphilis Revenue and Growth Rate (2013-2018)
4.3 Europe Neurosyphilis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Neurosyphilis Revenue and Growth Rate (2013-2018)
4.5 South America Neurosyphilis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Neurosyphilis Revenue and Growth Rate (2013-2018)
5 North America Neurosyphilis Revenue by Countries
5.1 North America Neurosyphilis Revenue by Countries (2013-2018)
5.2 USA Neurosyphilis Revenue and Growth Rate (2013-2018)
5.3 Canada Neurosyphilis Revenue and Growth Rate (2013-2018)
5.4 Mexico Neurosyphilis Revenue and Growth Rate (2013-2018)
6 Europe Neurosyphilis Revenue by Countries
6.1 Europe Neurosyphilis Revenue by Countries (2013-2018)
6.2 Germany Neurosyphilis Revenue and Growth Rate (2013-2018)
6.3 UK Neurosyphilis Revenue and Growth Rate (2013-2018)
6.4 France Neurosyphilis Revenue and Growth Rate (2013-2018)
6.5 Russia Neurosyphilis Revenue and Growth Rate (2013-2018)
6.6 Italy Neurosyphilis Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Neurosyphilis Revenue by Countries
7.1 Asia-Pacific Neurosyphilis Revenue by Countries (2013-2018)
7.2 China Neurosyphilis Revenue and Growth Rate (2013-2018)
7.3 Japan Neurosyphilis Revenue and Growth Rate (2013-2018)
7.4 Korea Neurosyphilis Revenue and Growth Rate (2013-2018)
7.5 India Neurosyphilis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Neurosyphilis Revenue and Growth Rate (2013-2018)
8 South America Neurosyphilis Revenue by Countries
8.1 South America Neurosyphilis Revenue by Countries (2013-2018)
8.2 Brazil Neurosyphilis Revenue and Growth Rate (2013-2018)
8.3 Argentina Neurosyphilis Revenue and Growth Rate (2013-2018)
8.4 Colombia Neurosyphilis Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Neurosyphilis by Countries
9.1 Middle East and Africa Neurosyphilis Revenue by Countries (2013-2018)
9.2 Saudi Arabia Neurosyphilis Revenue and Growth Rate (2013-2018)
9.3 UAE Neurosyphilis Revenue and Growth Rate (2013-2018)
9.4 Egypt Neurosyphilis Revenue and Growth Rate (2013-2018)
9.5 Nigeria Neurosyphilis Revenue and Growth Rate (2013-2018)
9.6 South Africa Neurosyphilis Revenue and Growth Rate (2013-2018)
10 Global Neurosyphilis Market Segment by Type
10.1 Global Neurosyphilis Revenue and Market Share by Type (2013-2018)
10.2 Global Neurosyphilis Market Forecast by Type (2018-2023)
10.3 Asymptomatic Neurosyphilis Revenue Growth Rate (2013-2023)
10.4 Meningeal Neurosyphilis Revenue Growth Rate (2013-2023)
10.5 Meningovascular Neurosyphilis Revenue Growth Rate (2013-2023)
10.6 General Paresis Revenue Growth Rate (2013-2023)
10.7 Tabes Dorsalis Revenue Growth Rate (2013-2023)
11 Global Neurosyphilis Market Segment by Application
11.1 Global Neurosyphilis Revenue Market Share by Application (2013-2018)
11.2 Neurosyphilis Market Forecast by Application (2018-2023)
11.3 Hospital And Clinics Revenue Growth (2013-2018)
11.4 Medical Research Centers Revenue Growth (2013-2018)
11.5 Academic Institutes Revenue Growth (2013-2018)
12 Global Neurosyphilis Market Size Forecast (2018-2023)
12.1 Global Neurosyphilis Market Size Forecast (2018-2023)
12.2 Global Neurosyphilis Market Forecast by Regions (2018-2023)
12.3 North America Neurosyphilis Revenue Market Forecast (2018-2023)
12.4 Europe Neurosyphilis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Neurosyphilis Revenue Market Forecast (2018-2023)
12.6 South America Neurosyphilis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Neurosyphilis Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Neurosyphilis Picture
Table Product Specifications of Neurosyphilis
Table Global Neurosyphilis and Revenue (Million USD) Market Split by Product Type
Fi
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
